The MacDougall conference calendar got a make-over and we're so excited to share it! You can find it featured in our Q3 Newsletter https://t.co/q3zXIFM1qJ
Capital Health joins Kiyatec's clinical trial to validate a patient-specific predictor test to improve response to cancer therapies for glioblastoma and anaplastic astrocytoma.
https://t.co/XOKoeL51m4
Positive results from study of #EV3D cell culture platform to predict #ovarian#cancer patient response to first line drugs provide clinical validation for ovarian assay and platform across range of solid tumor types. https://t.co/XA9mYXuZmT @SciReports https://t.co/9D5T76cuVh
@synlogic_tx announced that their Synthetic Biotic therapeutic, SYNB1618, is safe and tolerable in patients with #PKU. Synlogic is creating a pipeline of Synthetic Biotic #LivingMedicines to treat a variety of diseases, for more information check out their website!
Synlogic reports positive top-line data from Phase 1/2a study of SYNB1618 in patients with phenylketonuria and guides to next phase of development https://t.co/tARqmsdmrs
A look at how #ParkinsonsDisease could originate in the gut. Pathogenic a-Synuclein (a protein) could originate in the gut and travel via the vagal nerve to the brain and lead to PD. https://t.co/2s4Ggcu68p
Injecting engineered dying cells directly into a #tumor triggered the #immune system to attack tumor cells at multiple sites around the body, @snyderses, @andrewoberst, and their @UW colleagues found in mice. New in @SciImmunology: https://t.co/6jPamlxSAg #immunotherapy
Don't forget to tune into @BusinessWire's "Best Practices for #Biotech Communications Professionals," starting at 2:00 PM ET today. MacDougall Co-Founder and Managing Partner Kari Watson will be online to discuss effective #SciComm strategies. https://t.co/YnCqsKahlW @macbiokari
In today's guest blog, Paula Soteropoulos, CEO of @akceatx discusses why continuing & improving conversations among women CEOs is the #LifeSciences is critical to empower & support women, as well as overall #Diversity initiatives https://t.co/O4AoY42NPN #PathToDiversity